BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15286697)

  • 21. Reactive oxygen species and molecular mechanism of silica-induced lung injury.
    Shi X; Ding M; Chen F; Wang L; Rojanasakul Y; Vallyathan V; Castranova V
    J Environ Pathol Toxicol Oncol; 2001; 20 Suppl 1():85-93. PubMed ID: 11570677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor-beta (TGF-beta) in silicosis.
    Jagirdar J; Begin R; Dufresne A; Goswami S; Lee TC; Rom WN
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1076-81. PubMed ID: 8887610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The potential role of cytokine expression and its relation to angiogenesis in idiopathic pulmonary fibrosis].
    Cao B; Guo Z; Xu W; Zhu Y
    Zhonghua Nei Ke Za Zhi; 1999 Dec; 38(12):814-6. PubMed ID: 11798723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis of pulmonary fibrosis: platelet-derived growth factor precedes structural alterations in the Hermansky-Pudlak syndrome.
    Harmon KR; Witkop CJ; White JG; King RA; Peterson M; Moore D; Tashjian J; Marinelli WA; Bitterman PB
    J Lab Clin Med; 1994 Apr; 123(4):617-27. PubMed ID: 8145011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor beta1, ras and p53 in silica-induced fibrogenesis and carcinogenesis.
    Williams AO; Saffiotti U
    Scand J Work Environ Health; 1995; 21 Suppl 2():30-4. PubMed ID: 8929685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The potential role of cytokines expression in idiopathic pulmonary fibrosis].
    Guo Z; Cao B; Zhu Y; Xu W
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Jan; 22(1):33-6. PubMed ID: 11812353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of transforming growth factor-beta1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy.
    Li RK; Li G; Mickle DA; Weisel RD; Merante F; Luss H; Rao V; Christakis GT; Williams WG
    Circulation; 1997 Aug; 96(3):874-81. PubMed ID: 9264495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of antifibrotic action of interferon gamma-1b in pulmonary fibrosis.
    Ziesche R; Block LH
    Wien Klin Wochenschr; 2000 Sep; 112(18):785-90. PubMed ID: 11072666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pulmonary fibrosis. The fibrogenic factors and therapeutic possibilities].
    Lozano J; Hermosa MJ; Sánchez Martín MM; Angel-Moreno A; de Lera JM; de la Vega M; Sánchez Ramos M; Pérez Arellano JL
    An Med Interna; 2000 Oct; 17(10):549-54. PubMed ID: 11109653
    [No Abstract]   [Full Text] [Related]  

  • 30. BCNU (1,3-bis-(2-chloroethyl)-1-nitrosurea) lung. Drug-induced pulmonary changes.
    Mitsudo SM; Greenwald ES; Banerji B; Koss LG
    Cancer; 1984 Aug; 54(4):751-5. PubMed ID: 6744207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Histiocytic lymphoma and pulmonary fibrosis in a female patient with essential thrombocythemia].
    Morla J; Pérez-Encinas M; Antela C; Pérez E; Barrio E
    Med Clin (Barc); 1993 Jan; 100(3):104-6. PubMed ID: 8426490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced pulmonary fibrosis.
    Selker RG; Jacobs SA; Moore PB; Wald M; Fisher ER; Cohen M; Bellot P
    Neurosurgery; 1980 Dec; 7(6):560-5. PubMed ID: 7207751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary fibrosis: a complication of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy.
    Ryan BR; Walters TR
    Cancer; 1981 Aug; 48(4):909-11. PubMed ID: 7272934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon-gamma for delayed pulmonary toxicity syndrome resistant to steroids.
    Suratt BT; Lynch DA; Cool CD; Jones RB; Brown KK
    Bone Marrow Transplant; 2003 May; 31(10):939-41. PubMed ID: 12748674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of pulmonary fibrosis in organ-cultured rat lung by cadmium chloride and transforming growth factor-beta1.
    Lin CJ; Yang PC; Hsu MT; Yew FH; Liu TY; Shun CT; Tyan SW; Lee TC
    Toxicology; 1998 May; 127(1-3):157-66. PubMed ID: 9699802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of c-jun and TGF-beta 1 in Fischer 344 rats during amiodarone-induced pulmonary fibrosis.
    Chung WH; Bennett BM; Racz WJ; Brien JF; Massey TE
    Am J Physiol Lung Cell Mol Physiol; 2001 Nov; 281(5):L1180-8. PubMed ID: 11597910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Electron microscopic studies on pathogenesis of idiopathic pulmonary fibrosis].
    Tang X; He B; Li G; Zhang H; Chai L
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Jan; 22(1):27-9. PubMed ID: 11812351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nitrosourea-induced lung diseases].
    Massin F; Coudert B; Foucher P; Lombard JN; Reybet-Degat O; Jeannin L; Camus P
    Rev Mal Respir; 1992; 9(6):575-82. PubMed ID: 1470749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current concepts in radiation enteritis and implications for future clinical trials.
    Nguyen NP; Antoine JE; Dutta S; Karlsson U; Sallah S
    Cancer; 2002 Sep; 95(5):1151-63. PubMed ID: 12209703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary effects of carmustine (bischloroethylnitrosourea, BCNU).
    Sweet DL
    Ann Intern Med; 1979 Jul; 91(1):132-3. PubMed ID: 464443
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.